A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

被引：0

作者：

Taiga Otsuka

Tsuyoshi Shirakawa

Mototsugu Shimokawa

Futa Koga

Yasunori Kawaguchi

Yujiro Ueda

Junichi Nakazawa

Azusa Komori

Satoshi Otsu

Shiho Arima

Masaru Fukahori

Yoshinobu Okabe

Akitaka Makiyama

Hiroki Taguchi

Takuya Honda

Taro Shibuki

Kenta Nio

Yasushi Ide

Toshihiko Mizuta

Kenji Mitsugi

Norio Ureshino

机构：

[1] Saga Medical Center Koseikan,Department of Medical Oncology

[2] Minato Medical Clinic,Department of Internal Medicine

[3] Fukuoka Wajiro Hospital,Department of Medical Oncology

[4] Karatsu Higashi-Matsuura Medical Association Center,Clinical Research Institute

[5] National Kyushu Cancer Center,Department of Biostatistics

[6] Yamaguchi University Graduate School of Medicine,Department of Hepatobiliary and Pancreatology

[7] Saga Medical Center Koseikan,Department of Gastroenterology

[8] Asakura Medical Association Hospital,Department of Hematology and Oncology

[9] Japanese Red Cross Kumamoto Hospital,Department of Medical Oncology

[10] Kagoshima City Hospital,Department of Medical Oncology and Hematology

[11] Oita University Faculty of Medicine,Digestive and Lifestyle Diseases

[12] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Internal Medicine, Division of Gastroenterology

[13] Kurume University Hospital,Department of Hematology/Oncology

[14] Japan Community Healthcare Organization Kyushu Hospital,Department of Gastroenterology

[15] Cancer Center,Department of Gastroenterology

[16] Gifu University Hospital,Department of Gastroenterology and Hepatology

[17] Saiseikai Sendai Hospital,Department of Internal Medicine

[18] Izumi General Medical Center,Department of Hepatobiliary and Pancreatic Oncology

[19] Nagasaki University Graduate School of Biomedical Sciences,Department of Medical Oncology

[20] Imari Arita Kyoritsu Hospital,Department of Internal Medicine

[21] Saga,Department of Internal Medicine

[22] National Cancer Center Hospital East,Department of Medical Oncology

[23] Sasebo Kyosai Hospital,Department of Medical Oncology

[24] Karatsu Red Cross Hospital,undefined

[25] Fujikawa Hospital,undefined

[26] Hamanomachi Hospital,undefined

[27] Kimitsu Chuo Hospital,undefined

来源：

International Journal of Clinical Oncology | 2021年 / 26卷

关键词：

Pancreatic cancer; FOLFIRINOX; Gemcitabine; Nab-paclitaxel; Propensity score analysis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：941 / 950

页数：9

共 50 条

[31] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States [J].

Sunnie Kim ;

James E. Signorovitch ;

Hongbo Yang ;

Oscar Patterson-Lomba ;

Cheryl Q. Xiang ;

Brian Ung ;

Monika Parisi ;

John L. Marshall .

Advances in Therapy, 2018, 35 :1564-1577

[32] Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel [J].

Sams, L. ;

Kruger, S. ;

Heinemann, V. ;

Bararia, D. ;

Haebe, S. ;

Alig, S. ;

Haas, M. ;

Zhang, D. ;

Westphalen, C. B. ;

Ormanns, S. ;

Metzger, P. ;

Werner, J. ;

Weigert, O. ;

von Bergwelt-Baildon, M. ;

Rataj, F. ;

Kobold, S. ;

Boeck, S. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (11) :2394-2401

[33] Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States [J].

Kim, Sunnie ;

Signorovitch, James E. ;

Yang, Hongbo ;

Patterson-Lomba, Oscar ;

Xiang, Cheryl Q. ;

Ung, Brian ;

Parisi, Monika ;

Marshall, John L. .

ADVANCES IN THERAPY, 2018, 35 (10) :1564-1577

[34] Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel [J].

L. Sams ;

S. Kruger ;

V. Heinemann ;

D. Bararia ;

S. Haebe ;

S. Alig ;

M. Haas ;

D. Zhang ;

C. B. Westphalen ;

S. Ormanns ;

P. Metzger ;

J. Werner ;

O. Weigert ;

M. von Bergwelt-Baildon ;

F. Rataj ;

S. Kobold ;

S. Boeck .

Clinical and Translational Oncology, 2021, 23 :2394-2401

[35] FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer [J].

Ay, Seval ;

Atci, Muhammed Mustafa ;

Arikan, Rukiye ;

Dulgar, Ozgecan ;

Ozyukseler, Deniz Tataroglu ;

Paksoy, Nail ;

Dogan, Izzet ;

Oztosun, Bugra ;

Tastekin, Didem ;

Oven, Basak Bala ;

Gumus, Mahmut .

JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) :465-471

[36] Safety and Efficacy of Gemcitabine Plus Nab-Paclitaxel for Metastatic Pancreatic Cancer Patients Undergoing Biliary Stent Placement [J].

Inoue, Tadahisa ;

Ibusuki, Mayu ;

Kitano, Rena ;

Sakamoto, Kazumasa ;

Kimoto, Satoshi ;

Kobayashi, Yuji ;

Ohashi, Tomohiko ;

Sumida, Yoshio ;

Nakade, Yukiomi ;

Ito, Kiyoaki ;

Yoneda, Masashi .

DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) :3298-3304

[37] Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer [J].

Kawaida, Hiromichi ;

Kono, Hiroshi ;

Amemiya, Hidetake ;

Saitou, Ryou ;

Yamamoto, Atsushi ;

Hosomura, Naohiro ;

Watanabe, Mitsuaki ;

Kimura, Ayako ;

Furuya, Shinji ;

Shimizu, Hiroki ;

Akaike, Hidenori ;

Kawaguchi, Yoshihiko ;

Sudo, Makoto ;

Itakura, Jun ;

Hayakawa, Hiroshi ;

Shindo, Hiroko ;

Takahashi, Ei ;

Takano, Shinichi ;

Fukasawa, Mitsuharu ;

Ichikawa, Shintaro ;

Fujii, Hideki ;

Ichikawa, Daisuke .

ANTICANCER RESEARCH, 2018, 38 (11) :6537-6542

[38] First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population [J].

Hatashima, Alycia ;

Arango, Matthew J. ;

Reardon, Joshua ;

Freeman, Tracelyn ;

Williams, Terence ;

McLaughlin, Eric M. ;

Abushahin, Laith .

FUTURE ONCOLOGY, 2022, 18 (20) :2521-2532

[39] Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study) [J].

Koga, Futa ;

Kawaguchi, Yasunori ;

Shimokawa, Mototsugu ;

Murayama, Kenichiro ;

Nakashita, Shunya ;

Oza, Noriko ;

Ureshino, Norio ;

Takahashi, Hirokazu ;

Ueda, Yujiro ;

Nakazawa, Junichi ;

Komori, Azusa ;

Otsu, Satoshi ;

Arima, Shiho ;

Fukahori, Masaru ;

Makiyama, Akitaka ;

Taguchi, Hiroki ;

Honda, Takuya ;

Shibuki, Taro ;

Nio, Kenta ;

Ide, Yasushi ;

Mizuta, Toshihiko ;

Shirakawa, Tsuyoshi ;

Otsuka, Taiga ;

Mitsugi, Kenji .

JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) :82-87

[40] Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer [J].

Ueno, Hideki ;

Ikeda, Masafumi ;

Ueno, Makoto ;

Mizuno, Nobumasa ;

Ioka, Tatsuya ;

Omuro, Yasushi ;

Nakajima, Takako Eguchi ;

Furuse, Junji .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) :595-603

← 1 2 3 4 5 →